Otolaryngology (ENT)

ENT Clinical Research

ENT disorders impact millions worldwide, affecting breathing, hearing, and quality of life. CenExel partners with sponsors to advance innovative ENT therapies through precise, patient-focused clinical research across diverse populations.

Studies Conducted
Across ENT indications
0 +
Trial Participants
Enrolled in ENT trials
0 +
Active Sites
Specialized ENT research locations
0
Overview

Leading ENT Clinical Research

Complex ENT trials require specialized expertise and advanced diagnostic capabilities. CenExel’s experienced teams support studies across ear, nose, and throat conditions — ensuring high-quality data and efficient execution from first-patient-in to last-patient-out.

Our sites integrate clinical expertise with cutting-edge tools to evaluate outcomes in respiratory, auditory, and sinus-related disorders.

We support a wide range of ENT conditions including sinusitis, hearing disorders, sleep apnea, and rare otolaryngology indications across adult and pediatric populations.

Conditions Covered

ENT Conditions We Research

Our ENT research sites support a broad spectrum of conditions — from common sinus and allergy disorders to complex hearing and airway diseases.

Chronic Sinusitis

Allergic Rhinitis

Nasal Polyps

Obstructive Sleep Apnea (OSA)

Tonsillitis

Hearing Loss

Tinnitus

Otitis Media

Deviated Septum

Laryngitis

Our Approach

Why Sponsors Choose CenExel for ENT

Our ENT expertise extends beyond patient enrollment—we deliver specialized clinical insight, streamlined operations, and high-quality data to support successful outcomes and regulatory confidence across ear, nose, and throat studies.

01

Specialized ENT Expertise

Our investigators and site teams have deep experience in ENT trials, ensuring accurate diagnosis and high-quality data collection.

02

Advanced Diagnostics

We utilize modern tools including imaging, endoscopy, and audiology testing to support precise clinical evaluations.

03

Diverse Patient Access

Access to broad and diverse patient populations enables faster recruitment and real-world representation.

04

Efficient Enrollment

Our recruitment strategies consistently meet enrollment goals with speed and accuracy.

Phase Coverage

Supported Trial Phases

CenExel supports early and late-phase ENT clinical trials — from first-in-human studies through Phase IV post-market research.

Active across all phases

Phase I

Phase II

Phase III

Phase IV

Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.

ENT Task Force

CenExel’s ENT task force brings together specialists in otolaryngology, respiratory care, and audiology. Our multidisciplinary approach ensures precise study execution across sinus, airway, and hearing-related conditions, delivering reliable outcomes across diverse patient populations.

Active Sites

15 Sites

CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood
Related Therapeutic Areas

Also in Gastroenterology & Related Areas

Therapeutic Area

Respiratory Health

Upper airway and breathing-related conditions including allergies and sleep disorders.

Therapeutic Area

Allergy & Immunology

Immune-related conditions impacting nasal and sinus health.

Therapeutic Area

Neurology

Conditions affecting hearing, tinnitus, and vestibular disorders.